| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Marburg Virus Disease | 7 | 2018 | 41 | 2.07 | Why? |
| Ebolavirus | 11 | 2019 | 834 | 1.47 | Why? |
| Hemorrhagic Fever, Ebola | 12 | 2019 | 1475 | 1.41 | Why? |
| Marburgvirus | 4 | 2018 | 71 | 1.20 | Why? |
| Ebola Vaccines | 3 | 2019 | 126 | 0.96 | Why? |
| Zika Virus | 5 | 2017 | 1924 | 0.95 | Why? |
| Enema | 1 | 2020 | 42 | 0.87 | Why? |
| Asthma | 8 | 2021 | 4383 | 0.84 | Why? |
| Pseudorabies | 1 | 2019 | 13 | 0.79 | Why? |
| Herpesvirus 1, Suid | 1 | 2019 | 18 | 0.78 | Why? |
| Intussusception | 1 | 2020 | 102 | 0.77 | Why? |
| Mice, Knockout | 3 | 2018 | 1815 | 0.73 | Why? |
| Zika Virus Infection | 5 | 2018 | 1920 | 0.71 | Why? |
| Ferrets | 7 | 2019 | 1201 | 0.66 | Why? |
| Influenza A Virus, H7N9 Subtype | 5 | 2019 | 415 | 0.65 | Why? |
| Disease Models, Animal | 13 | 2019 | 10998 | 0.64 | Why? |
| Animal Diseases | 1 | 2019 | 182 | 0.63 | Why? |
| Rift Valley Fever | 4 | 2019 | 39 | 0.62 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2018 | 610 | 0.59 | Why? |
| Zoonoses | 2 | 2020 | 3034 | 0.58 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.58 | Why? |
| Forced Expiratory Volume | 1 | 2017 | 632 | 0.55 | Why? |
| Quercetin | 1 | 2017 | 297 | 0.55 | Why? |
| Spirometry | 1 | 2017 | 524 | 0.55 | Why? |
| Neglected Diseases | 1 | 2019 | 381 | 0.53 | Why? |
| Allergy and Immunology | 1 | 2017 | 240 | 0.53 | Why? |
| Hypersensitivity | 3 | 2019 | 1137 | 0.50 | Why? |
| Influenza in Birds | 5 | 2019 | 528 | 0.50 | Why? |
| Rift Valley fever virus | 4 | 2019 | 48 | 0.48 | Why? |
| Guinea Pigs | 6 | 2018 | 420 | 0.48 | Why? |
| Testis | 1 | 2017 | 566 | 0.45 | Why? |
| Vaccines, Virus-Like Particle | 4 | 2017 | 312 | 0.44 | Why? |
| Animals | 42 | 2021 | 78931 | 0.42 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.42 | Why? |
| Viral Vaccines | 9 | 2020 | 7560 | 0.38 | Why? |
| Filoviridae Infections | 2 | 2018 | 13 | 0.37 | Why? |
| Severe Acute Respiratory Syndrome | 10 | 2020 | 12361 | 0.37 | Why? |
| Pediatrics | 4 | 2020 | 2969 | 0.36 | Why? |
| Glycoproteins | 3 | 2017 | 615 | 0.36 | Why? |
| Reassortant Viruses | 3 | 2018 | 287 | 0.35 | Why? |
| Food Hypersensitivity | 3 | 2017 | 397 | 0.34 | Why? |
| Nanospheres | 2 | 2017 | 34 | 0.34 | Why? |
| Mice | 15 | 2020 | 21357 | 0.33 | Why? |
| Disease Outbreaks | 12 | 2020 | 27595 | 0.31 | Why? |
| Asia | 4 | 2020 | 2399 | 0.28 | Why? |
| China | 22 | 2021 | 50654 | 0.25 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.25 | Why? |
| Vaccines, DNA | 3 | 2019 | 871 | 0.25 | Why? |
| Allergens | 3 | 2017 | 728 | 0.25 | Why? |
| Coronavirus Infections | 24 | 2020 | 253789 | 0.24 | Why? |
| Child | 24 | 2021 | 70012 | 0.24 | Why? |
| SARS Virus | 9 | 2020 | 13021 | 0.23 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Swine | 3 | 2019 | 3352 | 0.21 | Why? |
| Primates | 3 | 2018 | 584 | 0.21 | Why? |
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2019 | 29 | 0.20 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.20 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 7 | 2020 | 8843 | 0.20 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.20 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.20 | Why? |
| Humans | 76 | 2021 | 930598 | 0.20 | Why? |
| Electromagnetic Fields | 1 | 2019 | 34 | 0.19 | Why? |
| Mometasone Furoate | 1 | 2019 | 37 | 0.19 | Why? |
| Tiotropium Bromide | 1 | 2019 | 46 | 0.19 | Why? |
| Rabies virus | 1 | 2019 | 92 | 0.19 | Why? |
| Rabies Vaccines | 1 | 2019 | 106 | 0.19 | Why? |
| Transistors, Electronic | 1 | 2019 | 48 | 0.19 | Why? |
| Antibodies, Monoclonal | 5 | 2019 | 8041 | 0.19 | Why? |
| Hepatitis B e Antigens | 1 | 2019 | 99 | 0.19 | Why? |
| Webcasts as Topic | 1 | 2020 | 118 | 0.19 | Why? |
| Cockroaches | 1 | 2017 | 4 | 0.19 | Why? |
| Hindlimb | 1 | 2018 | 21 | 0.18 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.18 | Why? |
| Penaeidae | 1 | 2017 | 13 | 0.18 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.18 | Why? |
| Global Health | 7 | 2021 | 13911 | 0.18 | Why? |
| Respiratory Tract Infections | 2 | 2017 | 6817 | 0.18 | Why? |
| Influenza, Human | 7 | 2020 | 10779 | 0.18 | Why? |
| Infant Food | 1 | 2017 | 39 | 0.18 | Why? |
| Parietal Lobe | 1 | 2018 | 29 | 0.18 | Why? |
| Weaning | 1 | 2017 | 46 | 0.18 | Why? |
| Hepatitis B Antibodies | 1 | 2019 | 142 | 0.18 | Why? |
| Hemorrhagic Fever with Renal Syndrome | 1 | 2018 | 31 | 0.18 | Why? |
| Virus Replication | 3 | 2019 | 14331 | 0.18 | Why? |
| Charadriiformes | 1 | 2017 | 14 | 0.18 | Why? |
| Animal Migration | 1 | 2017 | 49 | 0.17 | Why? |
| Medication Reconciliation | 1 | 2017 | 41 | 0.17 | Why? |
| Filoviridae | 1 | 2018 | 70 | 0.17 | Why? |
| Anseriformes | 1 | 2017 | 32 | 0.17 | Why? |
| Immunocompetence | 1 | 2018 | 280 | 0.17 | Why? |
| Infant | 11 | 2021 | 30274 | 0.17 | Why? |
| Influenza A Virus, H5N8 Subtype | 1 | 2017 | 50 | 0.16 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.16 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.16 | Why? |
| Communicable Disease Control | 5 | 2021 | 29620 | 0.16 | Why? |
| Memory | 1 | 2018 | 137 | 0.16 | Why? |
| Immunomagnetic Separation | 1 | 2017 | 55 | 0.16 | Why? |
| Locomotion | 1 | 2018 | 130 | 0.16 | Why? |
| Pulmonary Medicine | 2 | 2020 | 706 | 0.16 | Why? |
| Yellow fever virus | 1 | 2018 | 205 | 0.16 | Why? |
| Urbanization | 1 | 2017 | 133 | 0.16 | Why? |
| Poultry | 4 | 2019 | 437 | 0.16 | Why? |
| Macaca fascicularis | 2 | 2019 | 1009 | 0.16 | Why? |
| Phlebovirus | 1 | 2017 | 106 | 0.16 | Why? |
| Electrochemical Techniques | 2 | 2019 | 406 | 0.16 | Why? |
| Adaptation, Biological | 1 | 2017 | 179 | 0.16 | Why? |
| Gold | 2 | 2017 | 592 | 0.16 | Why? |
| Betacoronavirus | 14 | 2020 | 204454 | 0.15 | Why? |
| Influenza A virus | 2 | 2018 | 2234 | 0.15 | Why? |
| Indonesia | 1 | 2020 | 1022 | 0.15 | Why? |
| Sexually Transmitted Diseases, Viral | 1 | 2017 | 115 | 0.15 | Why? |
| Infertility, Female | 1 | 2017 | 150 | 0.15 | Why? |
| Patient Acuity | 2 | 2020 | 1755 | 0.15 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.15 | Why? |
| Antibodies, Viral | 14 | 2021 | 51949 | 0.15 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2018 | 556 | 0.15 | Why? |
| Graphite | 1 | 2019 | 318 | 0.14 | Why? |
| Vietnam | 1 | 2020 | 1665 | 0.14 | Why? |
| Cooperative Behavior | 2 | 2020 | 1216 | 0.14 | Why? |
| Phylogeny | 9 | 2020 | 13341 | 0.14 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.14 | Why? |
| Drug Resistance, Viral | 2 | 2018 | 1083 | 0.14 | Why? |
| Receptors, Cell Surface | 1 | 2019 | 586 | 0.14 | Why? |
| Mice, Inbred BALB C | 6 | 2020 | 5814 | 0.14 | Why? |
| Single-Domain Antibodies | 1 | 2021 | 744 | 0.13 | Why? |
| Sf9 Cells | 3 | 2020 | 273 | 0.13 | Why? |
| Hong Kong | 6 | 2021 | 3361 | 0.13 | Why? |
| Sputum | 2 | 2019 | 1720 | 0.13 | Why? |
| Republic of Korea | 4 | 2020 | 5858 | 0.13 | Why? |
| Cross Reactions | 3 | 2020 | 4374 | 0.13 | Why? |
| London | 1 | 2020 | 2166 | 0.13 | Why? |
| Disease Reservoirs | 2 | 2020 | 1672 | 0.13 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Host Specificity | 1 | 2018 | 926 | 0.13 | Why? |
| New Zealand | 1 | 2020 | 2073 | 0.13 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.12 | Why? |
| Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.12 | Why? |
| Genetic Vectors | 2 | 2017 | 1600 | 0.12 | Why? |
| Animals, Wild | 2 | 2018 | 1028 | 0.12 | Why? |
| Poultry Diseases | 1 | 2018 | 588 | 0.12 | Why? |
| Antiviral Agents | 9 | 2018 | 41703 | 0.12 | Why? |
| Infertility, Male | 1 | 2017 | 322 | 0.12 | Why? |
| Eosinophils | 1 | 2019 | 848 | 0.12 | Why? |
| Evolution, Molecular | 4 | 2020 | 3691 | 0.12 | Why? |
| Health Services | 1 | 2019 | 765 | 0.12 | Why? |
| Ribavirin | 3 | 2004 | 1182 | 0.12 | Why? |
| Child, Preschool | 11 | 2021 | 36283 | 0.12 | Why? |
| Neuraminidase | 3 | 2019 | 289 | 0.12 | Why? |
| Desensitization, Immunologic | 1 | 2017 | 574 | 0.12 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.12 | Why? |
| Female | 30 | 2021 | 380317 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Taiwan | 1 | 2020 | 2556 | 0.11 | Why? |
| Gastrointestinal Tract | 1 | 2020 | 1113 | 0.11 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2018 | 13720 | 0.11 | Why? |
| Viral Load | 5 | 2019 | 15850 | 0.11 | Why? |
| Hepatitis B virus | 1 | 2019 | 882 | 0.11 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2020 | 11367 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2019 | 1001 | 0.11 | Why? |
| Crystallography, X-Ray | 4 | 2021 | 2689 | 0.11 | Why? |
| Viral Envelope Proteins | 3 | 2019 | 3539 | 0.11 | Why? |
| Lung | 3 | 2021 | 31049 | 0.11 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.11 | Why? |
| Hepatitis B | 1 | 2019 | 888 | 0.11 | Why? |
| Patient Isolation | 2 | 2020 | 3182 | 0.10 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.10 | Why? |
| Survival Analysis | 3 | 2018 | 7592 | 0.10 | Why? |
| Genetic Variation | 3 | 2020 | 3919 | 0.10 | Why? |
| Rhinitis | 1 | 2017 | 626 | 0.10 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2017 | 830 | 0.10 | Why? |
| Vero Cells | 4 | 2020 | 14117 | 0.10 | Why? |
| Genome, Viral | 4 | 2020 | 13157 | 0.10 | Why? |
| Viral Matrix Proteins | 1 | 2017 | 1243 | 0.10 | Why? |
| Viral Proteins | 2 | 2019 | 7370 | 0.10 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.09 | Why? |
| Disease Susceptibility | 2 | 2021 | 4002 | 0.09 | Why? |
| Recombination, Genetic | 1 | 2016 | 1265 | 0.09 | Why? |
| Swine Diseases | 1 | 2019 | 1219 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.09 | Why? |
| Environmental Exposure | 1 | 2019 | 1558 | 0.09 | Why? |
| Epitopes | 2 | 2019 | 4113 | 0.09 | Why? |
| Infant, Newborn | 5 | 2021 | 23105 | 0.09 | Why? |
| Longitudinal Studies | 3 | 2019 | 9893 | 0.09 | Why? |
| Vaccination | 5 | 2020 | 19050 | 0.09 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.09 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.09 | Why? |
| Coronavirus | 4 | 2020 | 18339 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.08 | Why? |
| Male | 21 | 2021 | 367725 | 0.08 | Why? |
| Pandemics | 16 | 2021 | 389249 | 0.08 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
| Immunity, Cellular | 2 | 2017 | 3614 | 0.08 | Why? |
| Australia | 1 | 2020 | 6306 | 0.08 | Why? |
| Cricetinae | 3 | 2020 | 3344 | 0.08 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.08 | Why? |
| Pyrazines | 1 | 2018 | 1783 | 0.08 | Why? |
| Pharmacists | 1 | 2017 | 1246 | 0.08 | Why? |
| Chiroptera | 2 | 2020 | 3530 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2019 | 4020 | 0.08 | Why? |
| Amides | 1 | 2018 | 1864 | 0.08 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.08 | Why? |
| Feces | 1 | 2020 | 4235 | 0.08 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.08 | Why? |
| Immunity, Humoral | 2 | 2019 | 4849 | 0.08 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.07 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2020 | 5164 | 0.07 | Why? |
| Limit of Detection | 3 | 2019 | 2698 | 0.07 | Why? |
| T-Lymphocytes | 3 | 2019 | 6670 | 0.07 | Why? |
| Patient Discharge | 2 | 2020 | 5696 | 0.07 | Why? |
| Interferon-alpha | 1 | 2013 | 1442 | 0.07 | Why? |
| Genotype | 3 | 2019 | 4697 | 0.07 | Why? |
| Pyrimidinones | 1 | 2004 | 76 | 0.07 | Why? |
| Sequence Homology | 2 | 2020 | 448 | 0.07 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.07 | Why? |
| Adjuvants, Immunologic | 3 | 2019 | 1709 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.07 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.06 | Why? |
| Prevalence | 4 | 2017 | 25773 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Pneumococcal Vaccines | 1 | 2008 | 571 | 0.06 | Why? |
| Blepharoptosis | 1 | 2002 | 31 | 0.06 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Ocular Hypertension | 1 | 2002 | 35 | 0.06 | Why? |
| India | 1 | 2020 | 11875 | 0.06 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.06 | Why? |
| Immunization, Passive | 1 | 2018 | 10067 | 0.06 | Why? |
| Travel | 2 | 2015 | 7220 | 0.06 | Why? |
| Bahamas | 1 | 2021 | 6 | 0.06 | Why? |
| Corneal Ulcer | 1 | 2002 | 50 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Geography | 2 | 2018 | 1801 | 0.06 | Why? |
| Cell Line, Tumor | 2 | 2020 | 3608 | 0.06 | Why? |
| Graves Disease | 1 | 2002 | 61 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.05 | Why? |
| Spodoptera | 1 | 2020 | 220 | 0.05 | Why? |
| RNA, Viral | 5 | 2020 | 32276 | 0.05 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2020 | 358 | 0.05 | Why? |
| Early Diagnosis | 2 | 2019 | 2443 | 0.05 | Why? |
| Hepatitis B Core Antigens | 1 | 2019 | 76 | 0.05 | Why? |
| Immunization | 2 | 2019 | 2019 | 0.05 | Why? |
| Molecular Epidemiology | 1 | 2004 | 1638 | 0.05 | Why? |
| Air Pollution | 1 | 2017 | 3504 | 0.05 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.05 | Why? |
| Hemagglutinins, Viral | 1 | 2019 | 176 | 0.05 | Why? |
| Ducks | 1 | 2018 | 120 | 0.05 | Why? |
| Magnetics | 1 | 2018 | 66 | 0.05 | Why? |
| Receptors, Virus | 3 | 2021 | 5659 | 0.05 | Why? |
| CHO Cells | 1 | 2020 | 831 | 0.04 | Why? |
| Serial Passage | 1 | 2017 | 126 | 0.04 | Why? |
| Cricetulus | 1 | 2020 | 936 | 0.04 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Transfection | 1 | 2020 | 864 | 0.04 | Why? |
| Chimera | 1 | 2016 | 83 | 0.04 | Why? |
| Cyclonic Storms | 1 | 2021 | 236 | 0.04 | Why? |
| Hepatitis B Surface Antigens | 1 | 2019 | 305 | 0.04 | Why? |
| Parvovirus, Canine | 1 | 2016 | 86 | 0.04 | Why? |
| Horses | 1 | 2018 | 474 | 0.04 | Why? |
| Beijing | 1 | 2020 | 912 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2019 | 540 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Africa, Western | 1 | 2017 | 363 | 0.04 | Why? |
| Bunyaviridae Infections | 1 | 2017 | 107 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2019 | 800 | 0.04 | Why? |
| Skin Tests | 1 | 2017 | 229 | 0.04 | Why? |
| Toll-Like Receptor 4 | 1 | 2019 | 390 | 0.04 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.04 | Why? |
| Luminescence | 1 | 2017 | 236 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2017 | 391 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Quantum Dots | 1 | 2017 | 129 | 0.04 | Why? |
| Mass Spectrometry | 1 | 2021 | 1165 | 0.04 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
| Yellow Fever | 1 | 2018 | 231 | 0.04 | Why? |
| Ireland | 1 | 2021 | 1456 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Cluster Analysis | 2 | 2017 | 3001 | 0.04 | Why? |
| Ecology | 1 | 2016 | 140 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 2 | 2019 | 11559 | 0.04 | Why? |
| Birds | 1 | 2017 | 412 | 0.04 | Why? |
| Protein Domains | 2 | 2019 | 6563 | 0.03 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.03 | Why? |
| Microscopy, Electron, Transmission | 1 | 2017 | 605 | 0.03 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.03 | Why? |
| Reproduction | 1 | 2017 | 259 | 0.03 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.03 | Why? |
| Fluorescent Dyes | 1 | 2018 | 536 | 0.03 | Why? |
| Oseltamivir | 1 | 2018 | 583 | 0.03 | Why? |
| Respiration Disorders | 1 | 2020 | 526 | 0.03 | Why? |
| Philippines | 1 | 2017 | 568 | 0.03 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 511 | 0.03 | Why? |
| Immunoassay | 2 | 2020 | 4485 | 0.03 | Why? |
| Capsid Proteins | 1 | 2016 | 365 | 0.03 | Why? |
| Biosensing Techniques | 2 | 2019 | 2116 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2021 | 2372 | 0.03 | Why? |
| Alphacoronavirus | 1 | 2018 | 392 | 0.03 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.03 | Why? |
| Th2 Cells | 1 | 2016 | 680 | 0.03 | Why? |
| Sensitivity and Specificity | 3 | 2019 | 22971 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Liver Transplantation | 1 | 2008 | 2864 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Glycosylation | 1 | 2017 | 1255 | 0.03 | Why? |
| DNA Primers | 1 | 2017 | 1170 | 0.03 | Why? |
| Consensus | 2 | 2017 | 6345 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Malaysia | 1 | 2017 | 1116 | 0.03 | Why? |
| Delphi Technique | 1 | 2017 | 1257 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2019 | 1562 | 0.03 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.03 | Why? |
| Biological Evolution | 1 | 2017 | 641 | 0.03 | Why? |
| Interferons | 1 | 2004 | 2885 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Virus Attachment | 1 | 2019 | 1259 | 0.03 | Why? |
| Virulence | 1 | 2019 | 2172 | 0.03 | Why? |
| Canada | 1 | 2004 | 6018 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.03 | Why? |
| Cats | 1 | 2018 | 1890 | 0.03 | Why? |
| Pharynx | 1 | 2019 | 1544 | 0.03 | Why? |
| Middle East | 1 | 2016 | 1418 | 0.03 | Why? |
| Erythrocytes | 1 | 2016 | 617 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Immunoglobulin G | 3 | 2019 | 21571 | 0.03 | Why? |
| Medication Adherence | 1 | 2020 | 1270 | 0.03 | Why? |
| Th1 Cells | 1 | 2016 | 1228 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Infection Control | 3 | 2004 | 23131 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Vaccines, Subunit | 1 | 2016 | 1088 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Virion | 1 | 2018 | 1444 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2017 | 1013 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.02 | Why? |
| Lopinavir | 1 | 2004 | 4308 | 0.02 | Why? |
| Structure-Activity Relationship | 1 | 2016 | 2219 | 0.02 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.02 | Why? |
| Viral Tropism | 1 | 2017 | 1329 | 0.02 | Why? |
| Ritonavir | 1 | 2004 | 4212 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2008 | 64 | 0.02 | Why? |
| DNA, Viral | 1 | 2019 | 2521 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2004 | 3630 | 0.02 | Why? |
| Virus Internalization | 2 | 2017 | 7921 | 0.02 | Why? |
| Clinical Trials as Topic | 2 | 2017 | 7330 | 0.02 | Why? |
| Respiratory Tract Diseases | 1 | 2016 | 1061 | 0.02 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2015 | 1316 | 0.02 | Why? |
| Netherlands | 1 | 2017 | 3533 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2004 | 6537 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Adenoviridae | 1 | 2013 | 1151 | 0.02 | Why? |
| Singapore | 1 | 2017 | 3641 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2019 | 3231 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.02 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Health Resources | 1 | 2019 | 2592 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2016 | 2262 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Saudi Arabia | 1 | 2016 | 4423 | 0.02 | Why? |
| Rural Population | 1 | 2017 | 2408 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Cytokines | 2 | 2017 | 15010 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Triage | 1 | 2004 | 7151 | 0.02 | Why? |
| Drug Design | 1 | 2017 | 2627 | 0.02 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2009 | 3198 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.02 | Why? |
| Health Behavior | 1 | 2021 | 4449 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.01 | Why? |
| Education, Medical | 1 | 2019 | 2461 | 0.01 | Why? |
| Pneumococcal Infections | 1 | 2008 | 562 | 0.01 | Why? |
| Drug Discovery | 1 | 2016 | 3092 | 0.01 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Hospitals, Teaching | 1 | 2009 | 1609 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2004 | 9706 | 0.01 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2009 | 2830 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Cross Infection | 2 | 2016 | 8675 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Masks | 1 | 2021 | 8528 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Double-Blind Method | 1 | 2008 | 5988 | 0.01 | Why? |
| Hospital Departments | 1 | 2004 | 831 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Radiography | 1 | 2003 | 1576 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Health Personnel | 1 | 2004 | 29646 | 0.01 | Why? |
| Inpatients | 1 | 2009 | 5161 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Risk | 1 | 2004 | 5288 | 0.01 | Why? |
| Nasopharynx | 1 | 2009 | 10224 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |
| Cohort Studies | 1 | 2009 | 36005 | 0.00 | Why? |